Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.

Cerqueira-Silva, Thiago; Andrews, Jason R; Boaventura, Viviane S; Ranzani, Otavio T; de Araújo Oliveira, Vinicius; Paixão, Enny S; Júnior, Juracy Bertoldo; Machado, Tales Mota; Hitchings, Matt DT; Dorion, Murilo; +10 more... Lind, Margaret L; Penna, Gerson O; Cummings, Derek AT; Dean, Natalie E; Werneck, Guilherme Loureiro; Pearce, Neil; Barreto, Mauricio L; Ko, Albert I; Croda, Julio; Barral-Netto, Manoel; (2022) Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. The Lancet Infectious diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(22)00140-2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(22)00140-2

Abstract

Share

Download

Filename: Cerqueira-Silva_etal_2022_Effectiveness-of-coronavac-chadox1-ncov.pdf

Description: This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar